SCHEMBL14702015

SCHEMBL14702015

CCSCCc1ccc(C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.48
CYP2A6 P11509 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
AGXT P21549 2/20 0.41
IDO1 P14902 2/20 0.41
HRH3 Q9Y5N1 1/20 0.39
KCNH2 Q12809 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
IGF1R P08069 1/20 0.38
ALOX15 P16050 1/20 0.38
GPR84 Q9NQS5 1/20 0.37
DAO P14920 1/20 0.37
RECQL P46063 1/20 0.37
ACHE P22303 1/20 0.36
CHKA P35790 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28774334 0.81 CYP1A2 (0.58) CYP1A2CYP2A6TAAR1IDO1KCNH2
SCHEMBL13799439 0.80 IDO1 (0.48) TAAR1AGXTIDO1KCNH2ALDH1A1
SCHEMBL13870180 0.77 CYP2C19 (0.61) CYP1A2TDP1L3MBTL1CYP2D6CYP2C19
SCHEMBL12337765 0.76 IDO1 (0.48) CYP1A2CYP2A6TAAR1IDO1TDP1
SCHEMBL14346666 0.76 CYP1A2 (0.52) CYP1A2CYP2A6TAAR1AGXTIDO1
SCHEMBL1709949 0.76 CYP1A2 (0.60) CYP1A2CYP2D6CYP2C19MEN1ALDH1A1
SCHEMBL11579733 0.75 ALDH1A1 (0.42) CYP1A2TDP1CYP2D6CYP2C19ALDH1A1
SCHEMBL11086271 0.74 CYP1A2 (0.50) CYP1A2CYP2A6TAAR1AGXTIDO1
SCHEMBL21628358 0.74 CYP1A2 (0.56) CYP1A2CYP2A6TAAR1AGXTIDO1
SCHEMBL10736820 0.74 CYP1A2 (0.50) CYP1A2CYP2A6TAAR1AGXTIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130041000-A1 NOVEL AZOLE COMPOUND AJINOMOTO CO., INC. (JP) 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130041000-A1 NOVEL AZOLE COMPOUND LPAR1, LPAR2, LPAR3 CYP1A2 549/4885CYP2A6 1144/4885TAAR1 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.